split-banner-image

POEMS

Closed

IBCSG 34-05/SWOG S0230: POEMS

BCT Study Chair:

Kelly-Anne Phillips

Phase III trial of LHRH analogue administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormonal receptor-negative breast cancer.

international

199

INTERNATIONAL

Total number of trial

participants internationally

australia & new zealand

56

AUSTRALIA & NEW ZEALAND

Total number of trial participants

in Australia and New Zealand

institutions

19

INSTITUTIONS

Total number of participating institutions

in Australia and New Zealand

POEMS PUBLICATIONS

2019

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.

Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Mosely A, Porter DJ, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow JR, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CF, Minasian LM, Meyskens Jr, FL, Gelber RD, Hortobagyi GN, Albain KS. Journal of the National Cancer Institute. 2019; 111(2):210-213, (doi: 10.1093/jnci/djy185; epub 27 Oct 2018), Journal

Gonadotropin-Releasing Hormone (GnRH) Agonists for Fertility Preservation: Is POEMS the Final Verse?

Yu B, Davidson NE. Journal of the National Cancer Institute. 2019; 111(2):111-112, https://doi.org/10.1093/jnci/djy188; epub 27/10/18, Editorial

2017

Final analysis of SWOG S0230/Prevention of early menopause study (POEMS).

Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Moseley A, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. SABCS 2017; P1-15-01 , Poster

2015

Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy.

Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partidge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens Jr FL, Gelber RD, Hortobagyi GN, Albain KS, for the POEMS/S0230 Investigators. New England Journal of Medicine 2015; 372923-932, Journal

2014

Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance)

Moore HCF, Unger JM, Phillips K-A, Boyle FM, Hitre E, Porter DJ, Francis PA, Minasian LM, Gelber RD, Goldstein LJ, Gomez HL, Vallejos C, Partridge AH, Dakhil SR, Martino S, Barlow WE, Fabian CJ, Meyskens FL, Hortobagyi GN, Albain KS J Clin Oncol 2014; 32:5s(suppl; abstr LBA505), Abstract

2011

Optimal adjuvant therapy for very young breast cancer patients.

Francis PA. The Breast 2011; 20(4):297-302, Journal